Kidney fibrosis: from mechanisms to therapeutic medicines
Rongshuang Huang(Sichuan University), Liang Ma(Guangdong Pharmaceutical University)
Cited by 646
Related Papers
Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
|Acta Diabetologica|2019|183
Gut microbiota–derived short-chain fatty acids and kidney diseases
|Drug Design Development and Therapy|2017|157
FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury
|Signal Transduction and Targeted Therapy|2022|106
Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence
|Nature Communications|2024|88
Inhibition of Fatty Acid–Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition
|Frontiers in Immunology|2020|52